Beverley Hunt

Beverley Jane Hunt FRCP, FRCPath, MD is professor of thrombosis & haemostasis at King's College, London, consultant in the departments of haematology, rheumatology and pathology and director of the Haemostasis Research Unit at Guy's and St Thomas' Foundation Trust, medical director of Lifeblood, the Thrombosis Charity and previous president of Walthamstow Hall Old Girls Association. She was educated at Walthamstow Hall and University of Liverpool.

Specialist interest and research

Professor Hunt is author and co-author of many peer-reviewed research articles. She has a specialist clinical and research interest in venous thromboembolism, thromboprophylaxis, antiphospholipid syndrome, lupus erythematosus, and obstetric haematology

Books

She is co-editor of The Obstetric Hematology Manual, and also of An Introduction to Vascular Biology: From Basic Science to Clinical Practice

Society memberships

She is the founder and co-lead of the British Society for Haematology Obstetric Haematology Group from 2004, a founder member of the society's Education Committee from 2009, and a member of the British Society for Haemostasis and Thrombosis, the International Society of Thrombosis and Haemostasis and is a Fellow of the Royal College of Physicians.

Contribution to national guidelines

She was the co-author of several reports and guidelines: the British Society of Haematology’s "Guidelines for TTP" in 2001 and 2002, and an advisor on the Royal College of Obstetricians and Gynaecologists: "Advice on preventing deep vein thrombosis for pregnant women travelling by air" produced in October 2001 and an advisor on the Royal College of Obstetricians guideline on: "Thromboprophylaxis in pregnancy" in 2004 and 2009.

She is a member of "The Independent Expert Panel on Venous Thromboembolism" 2005/6, and co-author on the "International Consensus report on the investigation and management of primary immune thrombocytopenia", the "Clinical guidelines for testing for heritable thrombophilia" co-author on the "Guideline for investigation and management of adults and children presenting with a thrombocytosis" the "Management of bleeding following major trauma: an updated European guideline".

She was a member of the National Institute for Health and Care Excellence (NICE) guidelines development group for: "reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital" published in 2010 and also the "Acute management of venous thromboembolism" published in 2012. On behalf of Lifeblood, the Thrombosis Charity, she was also a member of the committee producing the NICE Quality standards on VTE prevention.

Charity

Hunt is co-founder and Medical Director of Lifeblood, the Thrombosis Charity which campaigns to raise awareness of thrombosis—in particular the risk of hospital-acquired deep vein thrombosis by mandating risk assessment.

Awards

She was winner in the Diagnostic/Laboratory category winner at the NHS London Innovation awards 2009 for “Detection of antiphospholipid antibodies based in heparin resistance.”, and won the 2011 Research paper of the year at the BMJ Group for a paper entitled "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial" which was published in the Lancet (2010;376:23-32).

External links

• GSTS
• Lifeblood, the Thrombosis Charity
• CRASH-2 Trial
• WOMAN Study